Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PROC-001
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Preclinical
Sponsor : Fjärde AP-fonden
Deal Size : $54.1 million
Deal Type : Financing
SmartCella raises EUR 50 million to accelerate growth and commercialization
Details : The financing aims to fund the clinical development of PROC-001, which is being evaluated in the early-stage clinical trial studies for the treatment of cardiovascular diseases such as heart failure.
Brand Name : PROC-001
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
July 08, 2024
Lead Product(s) : PROC-001
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Preclinical
Sponsor : Fjärde AP-fonden
Deal Size : $54.1 million
Deal Type : Financing
LOOKING FOR A SUPPLIER?